top of page

Mwandishi:

Mhariri:

Imeboreshwa:

ULY CLINIC

Mhariri:

2 Aprili 2026, 16:07:23

Zaha inatibu nini?

Zaha ni jina la kibiashara la dawa azithromycin, inayotumika kutibu magonjwa mbalimbali yanayosababishwa na bakteria wanaodhurika na dawa hii.


Vimelea wanaodhuriwa na zaha


Bakteriwa wanaodhuriwa na zaha ni;


  • Chlamydia trachomatis

  • Chlamydophila pneumoniae

  • Haemophilus influenza

  • Moraxella catarrhalis

  • Mycoplasma pneumoniae

  • Neisseria gonorrhoeae

  • Staphylococcus aureus

  • Streptococcus agalactiae

  • Streptococcus pneumoniae

  • Streptococcus pneumoniae

  • Streptococcus pyogenes


Kumbuka

Unapaswa kuwasiliana na daktari wako kwa ushauri zaidi na tiba.


Magonjwa yanayotibiwa na zaha


Magonjwa yanayotibiwa na zaha ambayo yanasababishwa na vimelea vyake vimeorodheshwa hapo juu ni;


  • Maambukizi makali kwenye mapafu

  • Sinusaitizi kali

  • Nimonia ya jamii

  • Maambukizi ya wastani kwenye ngozi

  • Maambukizi kwenye urethra na shingo ya kizazi

  • Vidonda sehemu za siri

  • Maambukizi makali kwenye sikio

  • Nimonia ya jamii

  • Pharyngitis/tonsillitis

Imeandikwa:

2 Aprili 2026, 16:07:23

ULY CLINIC inashauri usitegemee au kufuata ushauri wowote uliyoona kwenye makala hii bila kuwasiliana kwanza na daktari wako. Kabla ya kuchukua hatua yoyote ya matibabu, hakikisha umepata ushauri rasmi kutoka kwa daktari wako ili kuepuka madhara yoyote yanayoweza kutokea.

​

Makala hii ni ya kielimu tu na haitumiki kama mbadala wa matibabu ya daktari.

Rejea za mada hii:

  1. Noedl H, et al.  Azithromycin combination therapy with artesunate or quinine for the treatment of uncomplicated Plasmodium falciparum malaria in adults: a randomized, phase 2 clinical trial in Thailand. Clin Infect Dis. 2006 Nov 15;43(10):1264-71. Epub 2006 Oct 12.

  2. Peters DH, et al. Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy. Drugs. 1992 Nov;44(5):750-99. doi: 10.2165/00003495-199244050-00007.

  3. McMullan BJ, et al.  Prescribing azithromycin. Aust Prescr. 2015 Jun;38(3):87-9. Epub 2015 Jun 1.

  4. Fohner AE, et al. Macrolide antibiotic pathway, pharmacokinetics/pharmacodynamics. Pharmacogenet Genomics. 2017 Apr;27(4):164-167. doi: 10.1097/FPC.0000000000000270.

  5. Champney WS, et al. Inhibition of 50S ribosomal subunit assembly in Haemophilus influenzae cells by azithromycin and erythromycin. Curr Microbiol. 2002 Jun;44(6):418-24.

  6. Champney WS, et al. Macrolide antibiotics inhibit 50S ribosomal subunit assembly in Bacillus subtilis and Staphylococcus aureus. Antimicrob Agents Chemother. 1995 Sep;39(9):2141-4.

  7. Dinos GP: The macrolide antibiotic renaissance. Br J Pharmacol. 2017 Sep;174(18):2967-2983. doi: 10.1111/bph.13936. Epub 2017 Aug 10.

bottom of page